Sarfraz Z, Ozair A, Bardhan M, Starosciak AK, et al. Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): Study protocol for a multicenter phase 1 clinical trial. BMC Cancer 2025 Dec 4. doi: 10.1186/s12885-025-15224.
PMID: 41339822